| CAS ID: | 11096-26-7 |
| Molecular Formula: | C22H22ClKN6O |
| Molecular Weight: | 461 g/mol |
| Monoisotopic Mass: | 460.118 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C22H22ClN6O.K/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22;/h4-7,9-12,30H,2-3,8,13-14H2,1H3;/q-1;+1 | See All |
| InChI Key: | OXCMYAYHXIHQOA-UHFFFAOYSA-N | |
| Smiles: | CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+] | See All |
| Molfile: | Download |
Reference Record 1
| PubMed ID | 26469975 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro,mice | Fibrosis Disease | Renal fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | Targeting miR-144 | ||
Trial Record 1
| ClinicalTrial ID | NCT01902511 | Disease | Liver fibrosis |
| Phase | Not Applicable | Status | Completed |
| First Received | July 18, 2013 | Last Verified | November 22, 2016 |
| Sponsor | Institute of Liver and Biliary Sciences, India | ||
| PubChem: | 11751549 |
| ChEMBL: |